Skip to main content
OpenTrials
Completed

NCT Number: NCT01847950

Effects of scFOS on Stool Frequency in People With Functionnal Constipation

The study aims to evaluate the effects of short-chain fructo-oligosaccharides on the frequency and constistency of stools in subjects with functional constipation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CRNH-CRV Avicenne Hospital

Bobigny, 93009, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • subjects with functional constipation

Exclusion criteria

  • subjects treated with laxative treatments
  • subjects consuming more than 25g/day of dietary fibres
  • pregnant women

Treatment and study plan

Short-chain fructo-oligosaccharides

Dietary Supplement

Short-chain fructo-oligosaccharides are consummed at 5g/day for 6 weeks

Maltodextrin

Dietary Supplement

Primary outcomes

  1. Frequency of stool emission

    Time frame: 6 weeks

Secondary outcomes

  1. Stool consistency (Bristol scale)

    Time frame: 6 weeks

Other outcomes

  1. Transit time

    Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

Syral

Industry

Registry information

Official study title

Randomized, Placebo-controlled Double-blind Study to Evaluate the Effects of Fructo-oligosachharides on Increase of Stool Frequency in Constipated People

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
May 7, 2013
Registry last updated
Oct 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.